Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2013, Vol. 18 ›› Issue (10): 1081-1085.

    Next Articles

Association analysis of polymorphisms in intron 2 of μ opioid receptor gene and effective dose in methadone maintenance treatment of heroin addiction

XIE Xiao-hu1,2, LIU Hui-fen1,2, Zhang Ya-hai1,2, CHEN Wei-sheng1, ZHUANG Ding-ding1, ZHANG Jian-bing3, ZHOU Wen-hua1,2,3   

  1. 1Ningbo Institute of Microcirculation and Henbane, Ningbo 315010, Zhejiang, China;
    2Laboratory of Behavioral Neuroscience, School of Medicine, Ningbo University, Ningbo 315010, Zhejiang, China;
    3Ningbo Addiction Research and Treatment Center, Ningbo 315010, Zhejiang, China
  • Received:2012-12-21 Revised:2013-08-21 Online:2013-10-26 Published:2013-09-30

Abstract: AIM: To explore the association between the single nucleotide polymorphisms (SNP) in intron 2 of the μ opioid receptor gene (OPRM1) and the effective dose in methadone maintenance treatment of heroin addiction.METHODS: The genotypes of the two SNPs (rs9479757, rs2075572) in 68 heroin dependent patients in methadone maintenance treatment were detected by TaqMan SNP genotyping technique, and the association between methadone dose and the two SNPs was analyzed.RESULTS: The frequencies of genotype and allele at rs9479757, rs2075572 were not significantly different between the high and low methadone dose groups (P>0.05). The average methadone daily dosages of various genotypes at the two SNPs were not significantly different (P>0.05).CONCLUSION: The polymorphisms (rs9479757, rs2075572) in intron 2 of the μ opioid receptor gene (OPRM1) may not play the major role in the effective dose in methadone maintenance treatment of heroin addiction.

Key words: μ opioid receptor, Gene polymorphism, Heroin, Methadone

CLC Number: